Literature DB >> 17294995

Echocardiographic and clinical abnormalities in patients with psoriasis.

I Biyik1, A Narin, M A Bozok, O Ergene.   

Abstract

We investigated the incidence and severity of echocardiographic and clinical abnormalities in patients with psoriasis and their relationship to the severity, duration and type of psoriasis and other related factors. A total of 216 psoriasis patients and 216 control subjects were included in this study. Left and right heart dimensions, wall thicknesses, wall motion abnormalities, valvular disturbances, and systolic and diastolic functions were examined using two-dimensional and Doppler echocardiographic techniques. Left ventricular hypertrophy, left ventricular diastolic dysfunction, left ventricular wall motion abnormalities and valvular pathologies, especially mitral and tricuspid valve prolapse, were significantly more frequent in patients with psoriasis. Systolic and diastolic blood pressures were significantly higher in psoriasis patients. Significant correlations were found between: (i) psoriasis vulgaris and tricuspid valve prolapse; (ii) palmo-plantar psoriasis and valvular pathologies; and (iii) disease duration and left ventricular diastolic dysfunction and systolic and diastolic blood pressures. Physicians should be aware that cardiovascular abnormalities are common in patients with psoriasis.

Entities:  

Mesh:

Year:  2006        PMID: 17294995     DOI: 10.1177/147323000603400608

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  9 in total

Review 1.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

Review 2.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

Review 3.  Management of cardiovascular disease risk in chronic inflammatory disorders.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

4.  Echocardiographic and electrocardiographic assessments in patients with psoriasis.

Authors:  Zeinab Aryanian; Iraj Jafaripour; Edris Kohneshin; Roghayeh Pourkia; Mohammad Taghi Hedayati Goudarzi; Soudabeh Tirgar Tabari; Azar Shirzadian Kebria; Farbod Zahedi Tajrishi; Mohammad Mostafa Ansari Ramandi
Journal:  Caspian J Intern Med       Date:  2021-03

5.  Influence of psoriasis on circulatory system function assessed in echocardiography.

Authors:  Sylwia Milaniuk; Aldona Pietrzak; Barbara Mosiewicz; Jerzy Mosiewicz; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2015-06-28       Impact factor: 3.017

6.  The relationship between total atrial conduction time and left atrial global strain in patients with psoriasis vulgaris.

Authors:  Hakan Duman; Nursel Dilek; Selami Demirelli; Sinan Inci; Handan Duman; Mustafa Çetin; Murtaza Emre Durakoğlugil
Journal:  Arch Med Sci       Date:  2019-01-30       Impact factor: 3.318

7.  The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk.

Authors:  A Magenta; M D'Agostino; S Sileno; L Di Vito; C Uras; D Abeni; F Martino; F Barillà; S Madonna; C Albanesi; M Napolitano; M C Capogrossi; G Melillo
Journal:  Oxid Med Cell Longev       Date:  2019-12-19       Impact factor: 6.543

8.  Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study.

Authors:  Abbas Alshami; Nasam Alfraji; Steven Douedi; Swapnil Patel; Mohammad Hossain; Deborah Alpert; Dawn Calderon
Journal:  BMC Cardiovasc Disord       Date:  2021-03-31       Impact factor: 2.298

9.  Subclinical Cardiac Organ Damage in Patients with Moderate to Severe Psoriasis.

Authors:  Anja Linde; Eva Gerdts; Kåre Steinar Tveit; Ester Kringeland; Helga Midtbø
Journal:  J Clin Med       Date:  2021-05-31       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.